Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Change in Inventory (2016 - 2024)

Perspective Therapeutics (CATX) has disclosed Change in Inventory for 15 consecutive years, with $16000.0 as the latest value for Q2 2024.

  • Quarterly Change in Inventory rose 200.0% to $16000.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $16000.0 through Jun 2025, up 107.08% year-over-year, with the annual reading at -$359000.0 for FY2023, 117.99% down from the prior year.
  • Change in Inventory hit $16000.0 in Q2 2024 for Perspective Therapeutics, up from -$27000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $1.9 million in Q2 2022 to a low of -$1.3 million in Q4 2021.
  • Historically, Change in Inventory has averaged $83647.1 across 5 years, with a median of $22000.0 in 2020.
  • Biggest YoY gain for Change in Inventory was 1163.49% in 2021; the steepest drop was 5836.36% in 2021.
  • Year by year, Change in Inventory stood at $22000.0 in 2020, then crashed by 5836.36% to -$1.3 million in 2021, then surged by 106.02% to $76000.0 in 2022, then tumbled by 234.21% to -$102000.0 in 2023, then skyrocketed by 115.69% to $16000.0 in 2024.
  • Business Quant data shows Change in Inventory for CATX at $16000.0 in Q2 2024, -$27000.0 in Q1 2024, and -$102000.0 in Q4 2023.